• Mashup Score: 13

    The emergence of COVID-19 had doctors racing to define and treat the new disease, but they soon discovered it was not the only novel illness caused by SARS-CoV-2. A subset of children infected by the virus also experienced abdominal pain, headaches, rashes and vomiting. This new set of symptoms was labeled multisystem inflammatory syndrome in children (MIS-C) and had many of its pediatric…

    Tweet Tweets with this article
    • RT @medical_xpress: COVID-19, #MIS-C and #Kawasakidisease share same immune response @ucsandiego @NatureComms https://t.co/1Hq8JIOFGm

  • Mashup Score: 9

    The emergence of COVID-19 had doctors racing to define and treat the new disease, but they soon discovered it was not the only novel illness caused by SARS-CoV-2. A subset of children infected by the virus also experienced abdominal pain, headaches, rashes and vomiting. This new set of symptoms was labeled multisystem inflammatory syndrome in children (MIS-C) and had many of its pediatric…

    Tweet Tweets with this article
    • COVID-19, #MIS-C and #Kawasakidisease share same immune response @ucsandiego @NatureComms https://t.co/1Hq8JIOFGm

  • Mashup Score: 1

    Adding infliximab to standard therapy with high-dose intravenous immunoglobulin plus high-dose aspirin may decrease fever duration and prevent coronary artery lesions in children with Kawasaki disease, study findings indicate.

    Tweet Tweets with this article
    • News: Adding infliximab to standard therapy may decrease fever duration and prevent coronary artery lesions in children with #KawasakiDisease, suggests a network meta-analysis from Ping-Tao Tseng & team published in @eBioMedicine https://t.co/9UEszAZqZr

  • Mashup Score: 0

    The American College of Rheumatology and the Vasculitis Foundation have released new guidelines for Kawasaki disease, focusing on diagnostic issues, high-risk patients and convalescent patient management. “Kawasaki disease continues to be an area of evolving understanding in clinical treatment,” said Mark Gorelik, MD, an assistant professor at Columbia University Vagelos College of

    Tweet Tweets with this article
    • The @ACRheum and the @VasculitisFound have released new guidelines for #KawasakiDisease prioritizing early diagnosis and #IVIG as the central therapy https://t.co/xGIbiJCGbV

  • Mashup Score: 4

    Shortly after the contours of the coronavirus disease 2019 (COVID-19) pandemic became apparent in early 2020, specific measures to reduce the risk of person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were implemented. By mid to late March 2020, recommendations for masking, social distancing, and school closures were in place in many areas, with other…

    Tweet Tweets with this article
    • Worldwide, the number of cases of #Kawasaki disease were dramatically reduced during COVID mitigation measures. This real-world experience adds to research data pointing to a novel respiratory virus as the etiologic agent of #Kawasakidisease. @LuriePedsID https://t.co/t0SykwqiE0 https://t.co/5QGPFWtJIs

  • Mashup Score: 0

    To assess the epidemiologic association between Kawasaki disease and common pediatric infectious diseases (PIDs) identified during the coronavirus disease 2019 (COVID-19) pandemic period to confirm whether the infection-triggered theory is a plausible hypothesis for the pathogenesis of Kawasaki disease.

    Tweet Tweets with this article
    • Triggering #Kawasaki disease might be associated with presently unidentified respiratory pathogen(s) that might be potentially acquired from both within and outside the household. @AeRyusuke #Kawasakidisease #Etiology #PediatricInfectiousDisease https://t.co/QMTxz9EIc2 https://t.co/kbCgk9vpIt